Rex Bright has been a member of the company’s board of directors and Chairman of the Compensation Committee since September 2014. Mr. Bright is a specialty pharmaceuticals and biotech executive with extensive experience in dermatology. Mr. Bright has spent over 20 years as a start-up and turnaround CEO, and most recently founded and served as President and CEO of SkinMedica until it was acquired by Allergan in 2012. Prior to SkinMedica, Mr. Bright was President of Allergan Skincare and spent 19 years at Johnson & Johnson leading their dermatology division, which included the launch of Retin-A. He served on the board of directors of RestorGenex, Inc. through the Company’s merger with Diffusion Pharmaceuticals in 2016. Mr. Bright currently is a member of the board of directors of Clarify Medical and MDRejuvenia. He completed executive programs at Harvard, Stanford, and Northwestern University, and holds a BA in business administration from Drury University in Springfield, Missouri.